Clinical trial

Dexamethasone in Cryptococcal Meningitis

NCT00000776

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE2

Study timeline

Registry last updated2021-10-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Meningitis, Cryptococcalunresolved

HIV Infectionsunresolved

Interventions

FlucytosineDRUG · verified · RxNorm: flucytosine

FluconazoleDRUG · verified · RxNorm: fluconazole

Amphotericin BDRUG · verified · RxNorm: amphotericin B

DexamethasoneDRUG · verified · RxNorm: dexamethasone

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Mapped research locations

The BronxNew York, United States3 New YorkNew York, United States2 ChicagoIllinois, United States2 MiamiFlorida, United States1 BirminghamAlabama, United States1 ColumbusOhio, United States1 Washington D.C.District of Columbia, United States1 BuffaloNew York, United States1 BrooklynNew York, United States1 San JuanPuerto Rico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00000776 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.